Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands.

D'Erme AM, Milanesi N, Agnoletti AF, Maio V, Massi D, Gola M.

Dermatol Ther. 2014 Jan-Feb;27(1):21-3. doi: 10.1111/dth.12035. Epub 2013 Mar 28.

PMID:
24502306
2.

Treatment of atopic eczema with oral alitretinoin.

Grahovac M, Molin S, Prinz JC, Ruzicka T, Wollenberg A.

Br J Dermatol. 2010 Jan;162(1):217-8. doi: 10.1111/j.1365-2133.2009.09522.x. Epub 2009 Nov 3. No abstract available.

PMID:
19886882
3.

Topical tacrolimus for the treatment of lichen simplex chronicus.

Aschoff R, Wozel G.

J Dermatolog Treat. 2007;18(2):115-7.

PMID:
17520470
4.

Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses.

Kubin ME, Hägg PM, Kokkonen N, Väyrynen JP, Haapasaari KM, Moilanen J, Kallioinen M, Hurskainen T, Tasanen K.

Eur J Dermatol. 2016 Jan-Feb;26(1):21-7. doi: 10.1684/ejd.2015.2691.

PMID:
26711698
5.

Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region.

Lynch PJ.

Dermatol Ther. 2004;17(1):8-19. Review.

PMID:
14756886
6.

[Vulval dermatitis: localized condition--serious problem].

Kozlovskaia VV, Tikhonovskaia IV.

Lik Sprava. 2012 Jul-Sep;(5):35-44. Review. Russian.

PMID:
23534270
7.

[Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].

Aguayo-Leiva IR, Urrutia S, Jaén-Olasolo P.

Actas Dermosifiliogr. 2011 Oct;102(8):616-22. doi: 10.1016/j.ad.2010.10.012. Epub 2011 Feb 26. Spanish. Erratum in: Actas Dermosifiliogr. 2011 Dec;102(10):839.

PMID:
21354545
8.

Dermacase. Lichen simplex chronicus.

Prajapati V, Barankin B.

Can Fam Physician. 2008 Oct;54(10):1391-3. Review. No abstract available.

10.

Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.

Bissonnette R, Worm M, Gerlach B, Guenther L, Cambazard F, Ruzicka T, Maares J, Brown TC.

Br J Dermatol. 2010 Feb 1;162(2):420-6. doi: 10.1111/j.1365-2133.2009.09572.x. Epub 2009 Nov 10.

PMID:
19906075
11.

Alitretinoin for the treatment of severe chronic hand eczema.

Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M.

Health Technol Assess. 2010 May;14 Suppl 1:39-46. doi: 10.3310/hta14Suppl1/06. Review.

12.
14.

An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.

Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL.

Clin Exp Dermatol. 2011 Mar;36(2):149-54. doi: 10.1111/j.1365-2230.2010.03955.x. Epub 2010 Nov 10.

PMID:
21070335
16.

Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal.

Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M.

Pharmacoeconomics. 2010;28(5):351-62. doi: 10.2165/11532160-000000000-00000. Review.

PMID:
20131924
17.

Lichen amyloidosus: a consequence of scratching.

Weyers W, Weyers I, Bonczkowitz M, Diaz-Cascajo C, Schill WB.

J Am Acad Dermatol. 1997 Dec;37(6):923-8.

PMID:
9418758
18.

Nail improvement during alitretinoin treatment: three case reports and review of the literature.

Milanesi N, D'Erme AM, Gola M.

Clin Exp Dermatol. 2015 Jul;40(5):533-6. doi: 10.1111/ced.12584. Epub 2015 Feb 16. Review.

PMID:
25682921
19.

Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.

Ruzicka T, Larsen FG, Galewicz D, Horváth A, Coenraads PJ, Thestrup-Pedersen K, Ortonne JP, Zouboulis CC, Harsch M, Brown TC, Zultak M.

Arch Dermatol. 2004 Dec;140(12):1453-9.

PMID:
15611422
20.

Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.

Gola M, D'Erme AM, Milanesi N, Marmugi L.

Dermatitis. 2013 Jul-Aug;24(4):166-9. doi: 10.1097/DER.0b013e3182987773.

PMID:
23857016

Supplemental Content

Support Center